Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis.
Massimo ImazioAlessandro AndreisFrancesco PiroliGeorge LazarosMarco GattornoMartin LewinterAllan L KleinAntonio BrucatoPublished in: Heart (British Cardiac Society) (2021)
In patients with RP, anti-IL-1 agents (anakinra and rilonacept) are efficacious for prevention of recurrences, without severe adverse events.
Keyphrases